Kyverna Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Kyverna Therapeutics, Inc. (KYTX) is 354.96M

According to Kyverna Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 354.96M. This represents a change of 19.53% compared to the average of 296.96M of the last 4 quarters.

Kyverna Therapeutics, Inc. (KYTX) Historical Enterprise Value (quarterly & annually)

How has KYTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Kyverna Therapeutics, Inc. over the last ten years is 4.40B. The current 354.96M Enterprise Value has changed 706.37% with respect to the historical average. Over the past ten years (40 quarters), KYTX's Enterprise Value was at its highest in in the September 2023 quarter at 1.28B. The Enterprise Value was at its lowest in in the December 2022 quarter at 0.

Kyverna Therapeutics, Inc. (KYTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Kyverna Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kyverna Therapeutics, Inc. (KYTX) Average Enterprise Value

How has KYTX Enterprise Value performed in the past?

The current Enterprise Value of Kyverna Therapeutics, Inc. (KYTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kyverna Therapeutics, Inc. (KYTX) Enterprise Value vs. Peers

How is KYTX’s Enterprise Value compared to its peers?

Kyverna Therapeutics, Inc.’s Enterprise Value is less than Allogene Therapeutics, Inc. (538.48M), greater than Lexeo Therapeutics, Inc. Common Stock (322.71M), less than Cabaletta Bio, Inc. (372.89M), less than Contineum Therapeutics, Inc. Class A Common Stock (433.19M), greater than Editas Medicine, Inc. (211.68M), greater than Mereo BioPharma Group plc (13.16M), greater than Atea Pharmaceuticals, Inc. (270.24M), less than Capricor Therapeutics, Inc. (1.21B), greater than Lyell Immunopharma, Inc. (255.36M), greater than Silence Therapeutics plc (321.81M),

Build a custom stock screener for Kyverna Therapeutics, Inc. (KYTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kyverna Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kyverna Therapeutics, Inc. (KYTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kyverna Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.